Long Island Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Sell
696
-1
-0.1% -$342 0.1% 83
2026
Q1
$245K Buy
697
+5
+0.7% +$1.78K 0.11% 80
2025
Q4
$226K Buy
+692
New +$220K 0.11% 81
2025
Q2
Sell
-692
Closed -$216K 83
2025
Q1
$216K Buy
+692
New +$204K 0.13% 73
2024
Q4
Sell
-692
Closed -$223K 73
2024
Q3
$223K Sell
692
-3
-0.4% -$981 0.15% 66
2024
Q2
$217K Sell
695
-14
-2% -$4.11K 0.15% 69
2024
Q1
$202K Buy
709
+1
+0.1% +$293 0.14% 71
2023
Q4
$204K Buy
+708
New +$193K 0.15% 73

Other funds holding AMGN

Long Island Wealth Management's AMGN Position: Q2 2026 in Review

Long Island Wealth Management reduced its Amgen (AMGN) stake by 0.14% in Q2 2026, selling an estimated $342 and leaving 696 shares worth $252K. The position accounts for 0.1% of the portfolio, ranked #83.

Long Island Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Long Island Wealth Management held 696 shares of Amgen worth $252K as of Q2 2026.
  • Long Island Wealth Management sold 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.1% of Long Island Wealth Management's portfolio in Q2 2026, its #83 holding.
  • Long Island Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Long Island Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.